Chronic Exposure to PCBs (Aroclor 1254) Exacerbates Obesity-Induced Insulin Resistance and Hyperinsulinemia in Mice

Author： Gray Sarah L.   Shaw Alyssa C.   Gagne Anthony X.   Chan Hing Man  

Publisher： Taylor & Francis Ltd

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.76, Iss.12, 2013-06, pp. : 701-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Obesity-Induced Hypertension: New Insights

By  

Current Pharmaceutical Design, Vol. 23, Iss. 31, 2017-12 ,pp. : 4620-4625

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic rapamycin treatment exacerbates metabolism and does not down-regulate mTORC2/Akt signaling in diabetic mice induced by high-fat diet and streptozotocin

By WangYan   HeZhi   LiXianhui   ChenWenwei   LuJiewen   ChenXiangping   CaoLiang  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 9, 2015-09 ,pp. : 604-609

Govi-Verlag

Access to resources Recommend Favorite

Aroclor 1254 inhibits tryptophan hydroxylase activity in rat brain

By Khan Izhar  

Archives of Toxicology, Vol. 78, Iss. 6, 2004-06 ,pp. : 316-320

Springer Publishing Company

Access to resources Recommend Favorite

Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice

By Fornai F.   Bassi L.   Torracca M.T.   Scalori V.   Corsini G.U.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 99-102

Elsevier

Access to resources Recommend Favorite

Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 4, 2015-12 ,pp. : 297-301

Bentham Science Publishers

Access to resources Recommend Favorite